Abstract
Background: Biological age is a better predictor of morbidity and mortality associated with chronic age-related diseases than chronological age. The estimated difference between biological and chronological age can reveal an individual’s rate of aging. Aim: The aim of this study was to assess the association of cardiovascular risk factors with the rate of aging in people without cardiovascular diseases. Materials and methods: We calculated biological artery age and found associations of “old” arteries and rate of aging with risk factors of cardiovascular diseases in 143 adults without cardiovascular diseases. The data were analyzed by their categorization into 3 tertiles using regression methods. Results: The increased biological age of the arteries compared to the chronological age was associated with the chronological age (p < 0.001; ОR = 0.55; 95% CI: 0.43–0.71) and hypertension (p = 0.002; ОR = 6.04; 95% CI: 1.98–18.42) in general group, age (p < 0.001; ОR = 0.45; 95% CI: 0.30–0.68), hypertension (p = 0.004; ОR = 12.79; 95% CI: 2.25–72.55) and family history of oncology (p = 0.036; ОR = 0.14; 95% CI: 0.02–0.88) in women subgroup and age (p = 0.001; ОR = 0.45; 95% CI: 0.28–0.76) and 3rd tertile of glycated hemoglobin (p = 0.041; ОR = 65.05; 95% CI: 1.19–3548.29) in men subgroup. Difference between biological and chronological age in a group of “old” arteries was associated with chronological age (p = 0.001; β = –1.24; 95% CI: –1.95…–0.53) and with chronological age (p < 0.001; β = 1.71; 95% CI: 1.06–2.36) and 3rd tertile of glycated hemoglobin (p = 0.009; β = –4.78; 95% CI: –8.32…–1.24) in group of “young” arteries. Conclusion: This study demonstrates that accelerated arterial aging is associated with hypertension and high levels of glycated hemoglobin.
Similar content being viewed by others
REFERENCES
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016, Lancet, 2017, vol. 390, no. 10100, pp. 1211–1259. https://doi.org/10.1016/S0140-6736(17)32154-2
Elliott, M.L., Caspi, A., Houts, R.M., Ambler, A., Broadbent, J.M., Hancox, R.J., et al., Disparities in the pace of biological aging among midlife adults of the same chronological age have implications for future frailty risk and policy, Nature Aging, 2021, vol. 1, no. 3, pp. 295–308. https://doi.org/10.1038/s43587-021-00044-4
Levine, M.E., Modeling the rate of senescence: Can estimated biological age predict mortality more accurately than chronological age, J. Gerontol. A Biol. Sci. Med. Sci., 2013, vol. 68, no. 6, pp. 667–674. https://doi.org/10.1093/gerona/gls233
Unnikrishnan, A., Freeman, W.M., Jackson, J., Wren, J.D., Porter, H., and Richardson, A., The role of DNA methylation in epigenetics of aging. Pharmacol. Ther., 2021, vol. 195, pp. 172–185. https://doi.org/10.1016/j.pharmthera.2018.11.001
Ren, X. and Kuan, P.F., RNAAgeCalc: A multi-tissue transcriptional age calculator, PLoS One, 2020, vol. 15, no. 8, p. e0237006. https://doi.org/10.1371/journal.pone.0237006
Putin, E., Mamoshina, P., Aliper, A., Korzinkin, M., Moskalev, A., Kolosov, A., et al., Deep biomarkers of human aging: Application of deep neural networks to biomarker development, Aging, 2016, vol. 8, no. 5, pp. 1021–1030. https://doi.org/10.18632/aging.100968
Krištić, J., Vučković, F., Menni, C., Klarić, L., Keser, T., Beceheli, I., et al., Glycans are a novel biomarker of chronological and biological ages, J. Gerontol. A Biol. Sci. Med. Sci., 2014, vol. 69, no. 7, pp. 779–789. https://doi.org/10.1093/gerona/glt190
Fedintsev, A., Kashtanova, D., Tkacheva, O., Strazhesko, I., Kudryavtseva, A., Baranova, A., et al., Markers of arterial health could serve as accurate non-invasive predictors of human biological and chronological age, Aging, 2017, vol. 9, no. 4, pp. 1280–1292. https://doi.org/10.18632/aging.101227
Urtamo, A., Jyväkorpi, S.K., Kautiainen, H., Pitkälä, K.H., and Strandberg, T.E., Major cardiovascular disease (CVD) risk factors in midlife and extreme longevity, Aging Clin. Exp. Res., 2020, vol. 32, no. 2, pp. 299–304. https://doi.org/10.1007/s40520-019-01364-7
Herrmann, M., Pusceddu, I., März, W., and Herrmann, W., Telomere biology and age-related diseases, Clin. Chem. Lab. Med., 2018, vol. 56, no. 8, pp. 1210–1222. https://doi.org/10.1515/cclm-2017-087
Crocco, P., De Rango, F., Dato, S., Rose, G., and Passarino, G., Telomere length as a function of age at population level parallels human survival curves, Aging, 2021, vol. 13, no. 1, pp. 204–218. https://doi.org/10.18632/aging.202498
Cawthon, R.M., Telomere measurement by quantitative PCR, Nucleic Acids Res., 2002, vol. 30, no. 10, p. e47.
Hillary, R.F., Stevenson, A.J., McCartney, D.L., Campbell, A., Walker, R.M., Howard, D.M., et al., Epigenetic measures of ageing predict the prevalence and incidence of leading causes of death and disease burden, Clin. Epigenetics, 2020, vol. 12, no. 115. https://doi.org/10.1186/s13148-020-00905-6
Nilsson, P.M., Early vascular aging in hypertension, Front. Cardiovasc. Med., 2020, vol. 7, no. 6. https://doi.org/10.3389/fcvm.2020.00006
Curcio, S., García-Espinosa, V., Castro, J.M., Peluso, G., Marotta, M., Arana, M., et al., High blood pressure states in children, adolescents, and young adults associate accelerated vascular aging, with a higher impact in females’ arterial properties, Pediatr. Cardiol., 2017, vol. 38, no. 4, pp. 840–852. https://doi.org/10.1007/s00246-017-1591-z
Mutambudzi, M., Díaz-Venegas, C., and Menon, S., Association between baseline glycemic markers (HbA1c) and 8-year trajectories of functional disability, J. Gerontol. A Biol. Sci. Med. Sci., 2019, vol. 74, no. 11, pp. 1828–1834. https://doi.org/10.1093/gerona/glz089
Ganguli, M., Beer, J.C., Zmuda, J.M., Ryan, C.M., Sullivan, K.J., Chang, C.-C.H., et al., Aging, diabetes, obesity, and cognitive decline: A population-based study, J. Am. Geriatr. Soc., 2020, vol. 68, no. 5, pp. 991–998. https://doi.org/10.1111/jgs.16321
Ong, A.L.C. and Ramasamy, T.S., Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming, Ageing Res. Rev., 2018, vol. 43, pp. 64–80. https://doi.org/10.1016/j.arr.2018.02.004
He, S. and Sharpless, N.E., Senescence in health and disease, Cell, 2017, vol. 169, no. 6, pp. 1000–1011. https://doi.org/10.1016/j.cell.2017.05.015
Funding
The study was funded by the Medical Scientific and Educational Center of the Moscow State University.
Author information
Authors and Affiliations
Contributions
Each author’s contribution to the research and preparation of the article is equal. All authors approved the final version of the article before publication.
Corresponding authors
Ethics declarations
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
The study was approved by the local ethics committee of Medical Scientific and Educational Center of the Moscow State University (protocol No. 5 as of September 10, 2018).
Informed consent was obtained from all individual participants involved in the study.
CONFLICT OF INTEREST
The authors of the work declare that they have no conflicts of interest.
Additional information
Translated by L. Solovyova
Publisher’s Note.
Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Akopyan, A.A., Strazhesko, I.D., Moskalev, A.A. et al. The Rate of Aging and Its Association with Risk Factors of Cardiovascular Diseases. Adv Gerontol 13, 148–155 (2023). https://doi.org/10.1134/S2079057024600228
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079057024600228